Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of membranous nephropathy: when and what for treatment.

Literature DB >> 15800117

Management of membranous nephropathy: when and what for treatment.

Daniel Cattran¹.

Abstract

Entities: Disease

Mesh：

Substances：
Immunosuppressive Agents

Year: 2005 PMID： 15800117 DOI： 10.1681/ASN.2005010028

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

Keyword Cloud
Cited

× No keyword cloud information.

64 in total

1. Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR).

Authors: Hitoshi Yokoyama; Takashi Taguchi; Hitoshi Sugiyama; Hiroshi Sato
Journal: Clin Exp Nephrol Date: 2012-02-23 Impact factor: 2.801

2. Differential risk of remission and ESRD in childhood FSGS.

Authors: Debbie S Gipson; Hyunsook Chin; Trevor P Presler; Caroline Jennette; Maria E Ferris; Susan Massengill; Keisha Gibson; David B Thomas
Journal: Pediatr Nephrol Date: 2006-01-05 Impact factor: 3.714

3. Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.

Authors: Chadwick E Barnes; William A Wilmer; Raul A Hernandez; Christopher Valentine; Leena S Hiremath; Tibor Nadasdy; Anjali A Satoskar; Rose L Shim; Brad H Rovin; Lee A Hebert
Journal: Nephron Clin Pract Date: 2011-07-08

Management of membranous nephropathy: when and what for treatment.

1. Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR).

2. Differential risk of remission and ESRD in childhood FSGS.

3. Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.

4. Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy.

5. Membranous nephropathy secondary to Graves' disease with deposits of thyroid peroxidase in an adult.

6. A case of gefitinib-associated membranous nephropathy in treatment for pulmonary adenocarcinoma.

Review 7. Pathogenesis of membranous nephropathy: recent advances and future challenges.

Review 8. Novel biomarkers in glomerular disease.

9. Management of Membranous Nephropathy in the PLA₂R Era.

Review 10. Rituximab therapy for membranous nephropathy: a systematic review.